Prospective Validation of a Risk Prediction Model for MDRGNB Infection: A Multicenter Real-World Prospective Study
Prospective Validation of a Risk Prediction Model for MDRGNB Infection: A Multicenter Real-World Prospective Study
This prospective multicenter validation study aimed to evaluate the predictive performance of a previously developed model for MDRGNB infection in ICU patients.
Adult ICU patients were prospectively and consecutively enrolled across 11 research centers. MDRGNB infection risk predictions were generated within 24 hours of ICU admission using routinely available clinical data. Without interfering with clinical decision-making, the study assessed the discrimination, calibration, and clinical net benefit of the previously developed MDRGNB infection risk prediction model in real-world practice, applying the predefined threshold of 0.318.
Inclusion Criteria:
Exclusion Criteria:
cdy_pharmacy@njglyy.com+86-025-83106666-60924
hejuanwin@126.com
Nanjing, Jiangsu 210008, China
cdy_pharmacy@njglyy.com+86-025-83106666-60924
Huaian, China
1204624315@qq.com0517-84907287
18704630749@163.com+86-0915-3368788
Fxm10010@163.com+86-0352-7028190
liupei0322@163.com+86-0797-8266000
szy1066@126.com+86-0571-87987373
chenxiaoyuan@hmc.edu.cn+86-0571-87666666
1044548733@qq.com+86-0771-5331955
hejuanwin@126.com+86-021-64370045
caolu_cpu@163.com+86-029-85251331
nkyy_cx@126.com+86-0759-3157999